DCF — ST. LUKES ELMORE MEDICAL CENTER
Enterprise Value: $-27.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-27.8M
Enterprise Value
$-9.9M
PV of Cash Flows
$-17.9M
PV of Terminal Value
$-28.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $49.4M | $-1.1M | -2.0% | $-3.2M | $-2.9M |
| Year 2 | $50.9M | $-0.7M | -1.0% | $-2.8M | $-2.3M |
| Year 3 | $52.4M | $-0.2M | -0.0% | $-2.4M | $-1.8M |
| Year 4 | $54.0M | $0.1M | 0.0% | $-2.2M | $-1.5M |
| Year 5 | $55.6M | $0.2M | 0.0% | $-2.1M | $-1.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-27.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$47.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.028187462302062365
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5